– Late-breaking data from a head-to-head study evaluating SKYRIZI® (risankizumab) versus STELARA® (ustekinumab) in moderate to severe Crohn's disease will be presented – Analyses on clinical...

Genuine Parts Company (NYSE: GPC), a leading global distributor of automotive and industrial replacement parts, announced today that Paul Donahue, Chairman & CEO, Will Stengel, President & COO,...

In this free webinar, gain insights into the latest guidelines from the FDA and EMA on drug labeling in clinical pharmacology. Attendees will gain insights into how recent updates in regulatory...

Day Zero Lab Services launches new rapid high resolution organism ID service, epiXact® ID BOSTON, Oct. 10, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics...

Recorded Future, the world's largest intelligence company, demonstrated at their annual PREDICT 2023 conference how it is driving AI innovations across its Intelligence Cloud. Recorded Future's...